Disparities of trastuzumab use in resources limited or abundant regions and its survival benefit on HER2 positive breast cancer: a real world research from China
第一作者机构:[1]PLA, Mil Med Sci Acad, Affiliated Hosp, Beijing, Peoples R China;
推荐引用方式(GB/T 7714):
Li J.,Zhang H.,Wang S.,et al.Disparities of trastuzumab use in resources limited or abundant regions and its survival benefit on HER2 positive breast cancer: a real world research from China[J].BREAST.2017,32:S56-S56.doi:10.1016/S0960-9776(17)30196-0.
APA:
Li, J.,Zhang, H.,Wang, S.,Wang, Y.,Wang, X....&Jiang, Z..(2017).Disparities of trastuzumab use in resources limited or abundant regions and its survival benefit on HER2 positive breast cancer: a real world research from China.BREAST,32,
MLA:
Li, J.,et al."Disparities of trastuzumab use in resources limited or abundant regions and its survival benefit on HER2 positive breast cancer: a real world research from China".BREAST 32.(2017):S56-S56